Free Trial

Nostrum Oil & Gas (NOG) Competitors

Nostrum Oil & Gas logo
GBX 3.25 -0.25 (-7.14%)
As of 06:59 AM Eastern

NOG vs. EOG, BRY, MXC, HNR, and SUN

Should you buy Nostrum Oil & Gas stock or one of its competitors? MarketBeat compares Nostrum Oil & Gas with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nostrum Oil & Gas include Europa Oil & Gas (EOG), Brady (BRY), Argent BioPharma (MXC), Highlands Natural Resources (HNR), and Surgical Innovations Group (SUN). These companies are all part of the "petroleum and natural gas" industry.

How does Nostrum Oil & Gas compare to Europa Oil & Gas?

Nostrum Oil & Gas (LON:NOG) and Europa Oil & Gas (LON:EOG) are both small-cap energy companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

Europa Oil & Gas has lower revenue, but higher earnings than Nostrum Oil & Gas. Europa Oil & Gas is trading at a lower price-to-earnings ratio than Nostrum Oil & Gas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nostrum Oil & Gas£121.19M0.04-£121.71M-£235.00N/A
Europa Oil & Gas£3.57M5.48-£6.78M-£0.71N/A

Nostrum Oil & Gas currently has a consensus target price of GBX 4, indicating a potential upside of 23.08%. Given Nostrum Oil & Gas' stronger consensus rating and higher possible upside, equities research analysts clearly believe Nostrum Oil & Gas is more favorable than Europa Oil & Gas.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nostrum Oil & Gas
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Europa Oil & Gas
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

9.7% of Nostrum Oil & Gas shares are owned by institutional investors. Comparatively, 0.8% of Europa Oil & Gas shares are owned by institutional investors. 34.5% of Nostrum Oil & Gas shares are owned by insiders. Comparatively, 13.6% of Europa Oil & Gas shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Europa Oil & Gas had 1 more articles in the media than Nostrum Oil & Gas. MarketBeat recorded 2 mentions for Europa Oil & Gas and 1 mentions for Nostrum Oil & Gas. Nostrum Oil & Gas' average media sentiment score of 0.00 beat Europa Oil & Gas' score of -0.10 indicating that Nostrum Oil & Gas is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nostrum Oil & Gas
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Europa Oil & Gas
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Europa Oil & Gas has a net margin of -70.04% compared to Nostrum Oil & Gas' net margin of -184.95%. Nostrum Oil & Gas' return on equity of 88.74% beat Europa Oil & Gas' return on equity.

Company Net Margins Return on Equity Return on Assets
Nostrum Oil & Gas-184.95% 88.74% 1.53%
Europa Oil & Gas -70.04%-78.82%3.90%

Nostrum Oil & Gas has a beta of 0.718, meaning that its share price is 28% less volatile than the broader market. Comparatively, Europa Oil & Gas has a beta of 0.053, meaning that its share price is 95% less volatile than the broader market.

Summary

Nostrum Oil & Gas beats Europa Oil & Gas on 9 of the 15 factors compared between the two stocks.

How does Nostrum Oil & Gas compare to Brady?

Brady (LON:BRY) and Nostrum Oil & Gas (LON:NOG) are both small-cap petroleum and natural gas companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment.

In the previous week, Nostrum Oil & Gas had 1 more articles in the media than Brady. MarketBeat recorded 1 mentions for Nostrum Oil & Gas and 0 mentions for Brady. Brady's average media sentiment score of 0.00 equaled Nostrum Oil & Gas'average media sentiment score.

Company Overall Sentiment
Brady Neutral
Nostrum Oil & Gas Neutral

Brady has a net margin of 0.00% compared to Nostrum Oil & Gas' net margin of -184.95%. Nostrum Oil & Gas' return on equity of 88.74% beat Brady's return on equity.

Company Net Margins Return on Equity Return on Assets
BradyN/A N/A N/A
Nostrum Oil & Gas -184.95%88.74%1.53%

Brady has higher earnings, but lower revenue than Nostrum Oil & Gas. Nostrum Oil & Gas is trading at a lower price-to-earnings ratio than Brady, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Brady£22.16M0.00N/A-£3.70N/A
Nostrum Oil & Gas£121.19M0.04-£121.71M-£235.00N/A

Nostrum Oil & Gas has a consensus target price of GBX 4, suggesting a potential upside of 23.08%. Given Nostrum Oil & Gas' stronger consensus rating and higher possible upside, analysts plainly believe Nostrum Oil & Gas is more favorable than Brady.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Brady
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Nostrum Oil & Gas
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

9.7% of Nostrum Oil & Gas shares are owned by institutional investors. 34.5% of Nostrum Oil & Gas shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Nostrum Oil & Gas beats Brady on 9 of the 11 factors compared between the two stocks.

How does Nostrum Oil & Gas compare to Argent BioPharma?

Argent BioPharma (LON:MXC) and Nostrum Oil & Gas (LON:NOG) are both small-cap petroleum and natural gas companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

Nostrum Oil & Gas has a consensus target price of GBX 4, suggesting a potential upside of 23.08%. Given Nostrum Oil & Gas' stronger consensus rating and higher probable upside, analysts clearly believe Nostrum Oil & Gas is more favorable than Argent BioPharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Argent BioPharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Nostrum Oil & Gas
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Argent BioPharma and Argent BioPharma both had 1 articles in the media. Argent BioPharma's average media sentiment score of 0.00 equaled Nostrum Oil & Gas'average media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Argent BioPharma
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Nostrum Oil & Gas
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

1.2% of Argent BioPharma shares are owned by institutional investors. Comparatively, 9.7% of Nostrum Oil & Gas shares are owned by institutional investors. 8.2% of Argent BioPharma shares are owned by insiders. Comparatively, 34.5% of Nostrum Oil & Gas shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Argent BioPharma has a net margin of 0.00% compared to Nostrum Oil & Gas' net margin of -184.95%. Nostrum Oil & Gas' return on equity of 88.74% beat Argent BioPharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Argent BioPharmaN/A N/A -58.96%
Nostrum Oil & Gas -184.95%88.74%1.53%

Argent BioPharma has higher earnings, but lower revenue than Nostrum Oil & Gas. Nostrum Oil & Gas is trading at a lower price-to-earnings ratio than Argent BioPharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Argent BioPharma£1.32M0.00-£17.02M-£1.66N/A
Nostrum Oil & Gas£121.19M0.04-£121.71M-£235.00N/A

Argent BioPharma has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market. Comparatively, Nostrum Oil & Gas has a beta of 0.718, meaning that its stock price is 28% less volatile than the broader market.

Summary

Nostrum Oil & Gas beats Argent BioPharma on 8 of the 12 factors compared between the two stocks.

How does Nostrum Oil & Gas compare to Highlands Natural Resources?

Nostrum Oil & Gas (LON:NOG) and Highlands Natural Resources (LON:HNR) are both small-cap energy companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk.

In the previous week, Nostrum Oil & Gas had 1 more articles in the media than Highlands Natural Resources. MarketBeat recorded 1 mentions for Nostrum Oil & Gas and 0 mentions for Highlands Natural Resources. Nostrum Oil & Gas' average media sentiment score of 0.00 equaled Highlands Natural Resources'average media sentiment score.

Company Overall Sentiment
Nostrum Oil & Gas Neutral
Highlands Natural Resources Neutral

Nostrum Oil & Gas currently has a consensus target price of GBX 4, suggesting a potential upside of 23.08%. Given Nostrum Oil & Gas' stronger consensus rating and higher probable upside, analysts clearly believe Nostrum Oil & Gas is more favorable than Highlands Natural Resources.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nostrum Oil & Gas
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Highlands Natural Resources
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Highlands Natural Resources has a net margin of 0.00% compared to Nostrum Oil & Gas' net margin of -184.95%. Nostrum Oil & Gas' return on equity of 88.74% beat Highlands Natural Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Nostrum Oil & Gas-184.95% 88.74% 1.53%
Highlands Natural Resources N/A N/A N/A

Highlands Natural Resources has lower revenue, but higher earnings than Nostrum Oil & Gas. Nostrum Oil & Gas is trading at a lower price-to-earnings ratio than Highlands Natural Resources, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nostrum Oil & Gas£121.19M0.04-£121.71M-£235.00N/A
Highlands Natural Resources£1.02M0.00N/A-£4.90N/A

9.7% of Nostrum Oil & Gas shares are owned by institutional investors. 34.5% of Nostrum Oil & Gas shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Nostrum Oil & Gas beats Highlands Natural Resources on 9 of the 11 factors compared between the two stocks.

How does Nostrum Oil & Gas compare to Surgical Innovations Group?

Nostrum Oil & Gas (LON:NOG) and Surgical Innovations Group (LON:SUN) are both small-cap petroleum and natural gas companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

Nostrum Oil & Gas has a beta of 0.718, meaning that its stock price is 28% less volatile than the broader market. Comparatively, Surgical Innovations Group has a beta of 0.65, meaning that its stock price is 35% less volatile than the broader market.

In the previous week, Nostrum Oil & Gas and Nostrum Oil & Gas both had 1 articles in the media. Surgical Innovations Group's average media sentiment score of 0.75 beat Nostrum Oil & Gas' score of 0.00 indicating that Surgical Innovations Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nostrum Oil & Gas
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Surgical Innovations Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Surgical Innovations Group has lower revenue, but higher earnings than Nostrum Oil & Gas. Surgical Innovations Group is trading at a lower price-to-earnings ratio than Nostrum Oil & Gas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nostrum Oil & Gas£121.19M0.04-£121.71M-£235.00N/A
Surgical Innovations Group£11.60M0.40N/A-£0.10N/A

Nostrum Oil & Gas currently has a consensus target price of GBX 4, suggesting a potential upside of 23.08%. Given Nostrum Oil & Gas' stronger consensus rating and higher possible upside, equities analysts plainly believe Nostrum Oil & Gas is more favorable than Surgical Innovations Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nostrum Oil & Gas
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Surgical Innovations Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Surgical Innovations Group has a net margin of -4.96% compared to Nostrum Oil & Gas' net margin of -184.95%. Nostrum Oil & Gas' return on equity of 88.74% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Nostrum Oil & Gas-184.95% 88.74% 1.53%
Surgical Innovations Group -4.96%-6.04%-3.03%

9.7% of Nostrum Oil & Gas shares are held by institutional investors. Comparatively, 2.8% of Surgical Innovations Group shares are held by institutional investors. 34.5% of Nostrum Oil & Gas shares are held by company insiders. Comparatively, 21.5% of Surgical Innovations Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Nostrum Oil & Gas beats Surgical Innovations Group on 9 of the 13 factors compared between the two stocks.

Get Nostrum Oil & Gas News Delivered to You Automatically

Sign up to receive the latest news and ratings for NOG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NOG vs. The Competition

MetricNostrum Oil & GasOil & Gas E&P IndustryEnergy SectorLON Exchange
Market Cap£5.36M£2.08B£10.25B£2.79B
Dividend Yield5.36%7.61%10.46%6.13%
P/E Ratio-0.0133.0920.71364.81
Price / Sales0.042,727.39833.1887,608.26
Price / Cash0.0285.5338.4627.85
Price / Book-0.042.434.427.74
Net Income-£121.71M£82.07M£4.23B£5.88B
7 Day Performance8.33%1.65%1.77%6.68%
1 Month Performance6.56%-2.45%0.02%9.92%
1 Year Performance-14.02%52.09%51.42%75.85%

Nostrum Oil & Gas Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NOG
Nostrum Oil & Gas
1.3781 of 5 stars
GBX 3.25
-7.1%
GBX 4
+23.1%
-4.3%£5.36M£121.19MN/A30
EOG
Europa Oil & Gas
N/AGBX 1.52
+1.3%
N/A+168.7%£19.74M£3.57MN/A2,850
BRY
Brady
N/AN/AN/AN/A£15.17M£22.16MN/A1,370
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32MN/A5
HNR
Highlands Natural Resources
N/AN/AN/AN/A£6.95M£1.02MN/A16

Related Companies and Tools


This page (LON:NOG) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners